Aron Goldhirsch Selected Research

Adjuvant Chemotherapy

07/2007	Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93.
04/2007	Adjuvant chemotherapy (ECF regimen) for patients with gastric adenocarcinoma.
01/2007	Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII.
01/2007	2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.
03/2006	Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93.
10/2005	Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.
12/2003	Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial.
04/2003	Adjuvant chemotherapy in breast cancer: back to the future.

42	Breast Neoplasms (Breast Cancer) 09/2008 - 09/2002
3	Neoplasms (Cancer) 03/2008 - 06/2004
3	Carcinoma (Carcinomatosis) 09/2003 - 03/2003
1	Anemia 01/2008
1	Venous Thromboembolism 10/2007
1	Stomach Neoplasms (Stomach Cancer) 09/2007
1	Adenocarcinoma 04/2007
1	Hot Flashes 01/2007
1	Amenorrhea 01/2007
1	Hepatocellular Carcinoma (Hepatoma) 01/2007
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2006
1	Meningitis 09/2002
1	Colorectal Neoplasms (Colorectal Cancer) 04/2002

10	Tamoxifen FDA LinkGeneric 04/2008 - 06/2003
6	letrozole (Femara)FDA Link 04/2008 - 12/2005
4	HormonesIBA 09/2008 - 10/2004
4	trastuzumab (Herceptin)FDA Link 01/2007 - 10/2005
3	Cisplatin (Platino)FDA LinkGeneric 09/2008 - 09/2007
3	Fluorouracil (Carac)FDA LinkGeneric 09/2008 - 10/2005
3	Estrogens (Estrogen)FDA Link 03/2008 - 01/2006
2	Progesterone Receptors (Progesterone Receptor)IBA 03/2008 - 09/2007
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2008 - 10/2007
2	Goserelin (Zoladex)FDA Link 01/2007 - 12/2003
2	capecitabine (Xeloda)FDA Link 02/2006 - 04/2002
2	Methotrexate (Mexate)FDA LinkGeneric 01/2006 - 10/2005
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2006 - 10/2005
2	Biological Markers (Surrogate Marker)IBA 06/2003 - 03/2003
1	Epirubicin (Ellence)FDA LinkGeneric 09/2008
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2008
1	taxaneIBA 01/2008
1	fulvestrant (Faslodex)FDA Link 11/2007
1	Cancer VaccinesIBA 11/2007
1	Leucovorin (Folinic Acid)FDA LinkGeneric 09/2007
1	FPEPIR regimenIBA 04/2007
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 02/2007
1	erlotinib (CP 358,774)FDA Link 11/2006
1	vinorelbine (Navelbine)FDA LinkGeneric 02/2006
1	factor V LeidenIBA 01/2006
1	Toremifene (Fareston)FDA Link 12/2004
1	RNA (Ribonucleic Acid)IBA 06/2004
1	cadherin 5IBA 06/2004
1	anastrozole (Arimidex)FDA Link 06/2004
1	exemestane (Aromasin)FDA Link 09/2003
1	oxaliplatin (Eloxatin)FDA Link 04/2002